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In 2017, a chikungunya outbreak in central Italy later 
evolved into a secondary cluster in southern Italy, provid-
ing evidence of disease emergence in new areas. Officials 
have taken action to raise awareness among clinicians 
and the general population, increase timely case detec-
tion, reduce mosquito breeding sites, and promote mos-
quito bite prevention.
In 2007 (1) and 2017 (2), local outbreaks of human chi-kungunya infection occurred in Italy; both outbreaks 
were caused by the East/Central/South African strain of 
chikungunya virus (CHIKV). Both outbreaks were sus-
tained by the invasive mosquito Aedes albopictus, largely 
established in Italy and other countries in southern Eu-
rope (3). In 2017, France and Italy reported local trans-
mission of CHIKV (2,4). However, in France, the number 
of cases was limited; whereas in Italy, 499 probable and 
confirmed cases of locally acquired CHIKV infection oc-
curred, of which 270 were laboratory confirmed as per 
the European Union (EU) case definition of June 22, 2018 
(https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/ 
?uri=CELEX:32018D0945&from=EN#page=13).
 After local CHIKV transmission was confirmed in the 
seaside city of Anzio (Lazio region, central Italy) in 2017, 
the outbreak spread within the region, including in the city 
of Rome (5–7). The beginning of the outbreak was traced 
back to June 2017 (Figure 1). Subsequently, an outbreak 
developed in Guardavalle Marina, a small village of 2,346 
inhabitants in the Calabria region of southern Italy, causing 
100 probable/confirmed cases (Figures 1, 2).
The Cases
In August 2017, a patient from Anzio arrived in Guarda-
valle Marina the day before onset of symptoms that met the 
clinical criteria of the EU case definition for chikungunya 
(suspected case); subsequently, more cases in the village 
were reported. For most case-patients, the clinical course 
of the disease was fairly mild. All patients with confirmed/
probable cases reported fever, and 99% reported severe 
and persistent joint pain, which seemed to be the most 
indicative symptom of chikungunya (Appendix Table 2, 
https://wwwnc.cdc.gov/EID/article/25/11/18-0949-App1.
pdf). Phylogenetic analysis of isolates from patients with 
confirmed cases and from mosquito pools showed that the 
virus strains from Lazio and Calabria were similar to the 
East/Central/South African strains detected in Pakistan and 
India (2,8). Neither strain contained the A226V mutation 
that was detected in the strain responsible for the 2007 out-
break in Italy (1).
The epidemiologic and microbiological evidence (Ap-
pendix) supports the hypothesis that the Guardavalle Ma-
rina outbreak originated from Lazio rather than from an 
independent introduction. The overall clinically observed 
attack rate in Guardavalle Marina was 4.3%, similar to the 
5.4% rate reported during the 2007 outbreak in Castiglione 
di Cervia but much lower than the 34% rate reported in La 
Réunion (9) or the high attack rates typically reported by 
other affected tropical countries (10). The duration of the 
Guardavalle Marina outbreak (2 months) was also closer to 
the duration of the outbreak in Castiglione di Cervia (July–
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September 2007) than to the duration of the outbreak in La 
Réunion (March 2005–April 2006) (11). 
Clinically observed attack rates progressively in-
creased with patient age (Appendix Table 1). This pat-
tern was also observed during the 2007 outbreak in Italy 
(1) and was mainly attributed to older age being a proxy 
for specific behavior linked to higher exposure to bites 
from Ae. albopictus mosquitoes (12). We cannot exclude 
underestimation of the observed attack rate in Guarda-
valle Marina, even though extensive door-to-door case 
finding was feasible and performed, given the small size 
of the village.
Notwithstanding the lack of the A226V mutation, 
the 2017 strain was introduced and rapidly spread with 
evidence of disease emergence in new areas. Statistically 
significant case clustering was confirmed by spatiotempo-
ral data analysis in Guardavalle Marina (Appendix Figure 
2), and Ae. albopictus mosquito vector competence for the 
2017 strain was recently found to be comparable to compe-
tence for the 2007 mutated strain (13).
Delayed clinical detection of cases, possibly resulting 
from lack of CHIKV infection awareness among clinicians 
(14), and hence delayed testing for laboratory confirmation, 
could explain the size and extension of the 2017 outbreak. 
The fact that the outbreak was contained in a relatively 
short time after detection could be the result of the com-
bination of targeted vector control interventions (Appen-
dix), cooling temperatures, and increased rainfall during 
October–November 2017.
Conclusions
Since 2011, Italy has had a yearly updated plan for the 
surveillance and control of human infections caused by 
CHIKV; the plan includes designated reference laborato-
ries, vector control, and blood/transplant safety measures 
(Appendix). After the 2017 outbreak, a “presumed local 
cluster” was defined as occurring when local transmis-
sion of CHIKV is suspected for >2 cases, of which only 
1 case needs to be laboratory confirmed. It is sufficient for 
the second case to be suspected on clinical and epidemio-
logic grounds pending laboratory confirmation. This new 
definition, aimed at triggering more timely blood/transplant 
safety and outbreak response measures, was successfully 
implemented in 2018. Actions to raise awareness among 
clinicians and the general population are being designed as 
part of a joint effort of animal and human public health in-
stitutions and universities coordinated by the Italy Ministry 
of Health. These actions are aimed at increasing timely case 
detection, reducing the number of mosquito breeding sites, 
and promoting individual prevention of mosquito bites.
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Figure 1. Epidemic curve for 
499 cases of chikungunya 
(probable and confirmed) in 
central and southern Italy, June 
26–November 15, 2017.
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